Monitor future draws under the facility and any updates on the company's cash runway, particularly given the risk noted in the filing that available funds may be insufficient for operations.
Price Chart
Executive Summary
TuHURA Biosciences drew an additional $650,000 under its existing $50 million revolving credit facility with Parkview Holdings One LLC on September 21, 2026, for general corporate purposes. The facility matures on April 21, 2031. This is a routine draw on an already-disclosed credit line and does not represent new debt or a change in terms.
Key Facts
- TuHURA borrowed an additional $650,000 under its existing $50 million revolving credit facility on September 21, 2026.
- The facility was originally entered into on April 21, 2026, with Parkview Holdings One LLC as lender.
- The facility matures on April 21, 2031.
- Proceeds will be used for general corporate purposes.
Financial Impact
Additional draw of $650,000 on a $50 million facility; total drawn amount not disclosed.
Risk Factors
- The company may be unable to satisfy conditions for future drawdowns or maintain compliance with the loan agreement.
- Potential conflicts of interest as the lender is an affiliate of the company's largest stockholder.
- Funds available under the facility may be insufficient to fund operations and development programs as anticipated.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-401140 |
| Document: 0001193125-26-401140-index-headers.html | 0001193125-26-401140 |
| Document: 0001193125-26-401140-index.html | 0001193125-26-401140 |
| Document: 0001193125-26-401140.txt | 0001193125-26-401140 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 9d ago | 8-K | $1.78 | awaiting T+60 | — | $2.03 (+14.04%) |
Sep 24, 2026 4w ago | 8-K | $2.10 | awaiting T+60 | — | $2.03 (−3.33%) |
Sep 17, 2026 5w ago | 8-K | $2.10 | awaiting T+60 | — | $2.03 (−3.33%) |
Sep 16, 2026 5w ago | 8-K | $2.09 | awaiting T+60 | — | $2.03 (−2.87%) |
Sep 4, 2026 7w ago | 8-K | $2.12 | awaiting T+60 | — | $2.03 (−4.25%) |
Aug 19, 2026 9w ago | 8-K | $2.22 | awaiting T+60 | — | $2.03 (−8.56%) |
Aug 14, 2026 10w ago | 8-K | $2.47 | awaiting T+60 | — | $2.03 (−17.81%) |
Aug 14, 2026 10w ago | Press Release | $2.47 | awaiting T+60 | — | $2.03 (−17.81%) |
Aug 13, 2026 10w ago | 8-K | $2.47 | awaiting T+60 | — | $2.03 (−17.81%) |
Jul 29, 2026 12w ago | 8-K | $2.17 $2.18 | ▲ +0.46% | ▼ −2.00% | $2.03 (−6.45%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers